Here are five facts:
1. Royal Bank of Canada has an “outperform” rating on AmSurg shares.
2. The firm’s price objective indicates a 32.58 percent potential upside compared to AmSurg’s previous close.
3. On Jan. 5, AmSurg opened the day trading at $65.62.
4. The company’s 50-day moving average is $54.74 and a 200-day moving average is $30.30.
5. AmSurg’s market cap totals $3.53 billion.
More articles on surgery centers:
From total knees to hip arthoplasties: How Premier Orthopedic Surgery Center is tackling the evolving outpatient landscape
4 recent ASC acquisitions — Jan. 5, 2016
Envision Healthcare Corp. acquires Sunshine Radiology — 4 notes
